赛伦生物
(688163)
| 流通市值：36.69亿 | | | 总市值：36.69亿 |
| 流通股本：1.08亿 | | | 总股本：1.08亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 104,210,450.98 | 27,093,556.95 | 196,205,881.77 | 175,138,574.09 |
| 营业收入 | 104,210,450.98 | 27,093,556.95 | 196,205,881.77 | 175,138,574.09 |
| 二、营业总成本 | 65,411,608.53 | 28,203,094.58 | 140,513,815.84 | 105,193,973.75 |
| 营业成本 | 22,633,964.76 | 7,408,817.55 | 42,928,672.49 | 37,782,811.72 |
| 税金及附加 | 1,674,556.8 | 351,904.41 | 1,953,928.87 | 1,533,115.66 |
| 销售费用 | 19,528,468.32 | 10,023,113.23 | 55,042,236.07 | 37,265,131.66 |
| 管理费用 | 10,827,018.16 | 5,587,087.98 | 22,421,196.68 | 17,150,832.68 |
| 研发费用 | 10,678,265.77 | 4,800,348.65 | 19,508,321.24 | 12,878,600.46 |
| 财务费用 | 69,334.72 | 31,822.76 | -1,340,539.51 | -1,416,518.43 |
| 其中:利息费用 | 90,417.7 | 39,148.35 | 179,655.32 | 124,633.23 |
| 其中:利息收入 | 397,123.89 | 188,742.12 | 1,614,867.62 | 1,440,745.79 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,030,487.45 | 949,071.23 | 1,409,182.18 | 1,297,780.82 |
| 加:投资收益 | 3,784,309.65 | 2,180,740.55 | 9,175,924.27 | 6,380,500.14 |
| 资产处置收益 | 14,154.22 | -325,061.45 | 80,366.33 | - |
| 资产减值损失(新) | -2,158,254.63 | -676,262.46 | -2,075,092.97 | -1,211,414.94 |
| 信用减值损失(新) | -2,128,363.75 | -669,063.77 | -280,023.37 | -1,878,459.12 |
| 其他收益 | 212,773.06 | 123,133.96 | 504,649.73 | 497,430.05 |
| 四、营业利润 | 40,553,948.45 | 473,020.43 | 64,507,072.1 | 75,030,437.29 |
| 加:营业外收入 | 3,600 | - | 90,409.71 | 170,776.04 |
| 减:营业外支出 | 599,573.06 | 52,576.68 | 391,270.16 | 383,743.93 |
| 五、利润总额 | 39,957,975.39 | 420,443.75 | 64,206,211.65 | 74,817,469.4 |
| 减:所得税费用 | 4,306,671.03 | -146,732.4 | 12,418,815.13 | 10,606,814.59 |
| 六、净利润 | 35,651,304.36 | 567,176.15 | 51,787,396.52 | 64,210,654.81 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 35,651,304.36 | 567,176.15 | 51,787,396.52 | 64,210,654.81 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 35,651,304.36 | 567,176.15 | 51,787,396.52 | 64,210,654.81 |
| 扣除非经常损益后的净利润 | 31,083,190.44 | -2,090,410.7 | 42,632,839.88 | 56,435,671.82 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.33 | 0.01 | 0.48 | 0.59 |
| (二)稀释每股收益 | 0.33 | 0.01 | 0.48 | 0.59 |
| 九、综合收益总额 | 35,651,304.36 | 567,176.15 | 51,787,396.52 | 64,210,654.81 |
| 归属于母公司股东的综合收益总额 | 35,651,304.36 | 567,176.15 | 51,787,396.52 | 64,210,654.81 |
| 公告日期 | 2026-08-22 | 2026-04-25 | 2026-04-25 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |